Frances Kelsey’s role is crucial in the 1962 Thalidomide Reform in two ways. On the one hand, Kelsey’s delay for the marketing of Thalidomide saved many potential life losses and inspired a major component of Kevaufer-Harris reform, flipping sponsor-examiner dynamics for the first time in American history. On the other hand, she is a silent revolutionaire: she, as a woman living in the patriarchal 1960s, showcases to the public the female potential to influence major governmental decisions, and equate men in male dominated situations. She confronted two false gods: Thalidomide, and male pride. Kelsey's response and involvements with the thalidomide reform of 1962 tells of the poisonous debris of male hegemony that American society suffers from today.